IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.37B
1-Year Est. Return
69.45%
1 Year Est. Return
+69.45%
AUM
$1.37B
AUM Growth
+$301M
(+28%)
Holding
90
Top Buys
| 1 | +$22M | |
| 2 | +$20.9M | |
| 3 | +$16M | |
| 4 |
Centene
CNC
|
+$14.3M |
| 5 |
Doximity
DOCS
|
+$13.2M |
Top Sells
| 1 | +$45.5M | |
| 2 | +$43.8M | |
| 3 | +$24.4M | |
| 4 |
DexCom
DXCM
|
+$17.5M |
| 5 |
Encompass Health
EHC
|
+$15.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Eli Lilly
LLY
$973B
| $15.3M | 1.03% |
20,000
-5,000
|
|
||
27
CVS Health
CVS
$105B
| $15.1M | 1.02% |
200,000
-50,000
|
|
||
28
Tarsus Pharmaceuticals
TARS
$3.02B
| $14.9M | 1.01% |
250,000
+50,000
|
|
||
29
Medtronic
MDT
$130B
| $14.3M | 0.97% |
150,000
-50,000
|
|
||
|
30
Centene
CNC
$22.3B
| $14.3M | 0.97% |
+400,000
|
|
||
|
31
Doximity
DOCS
$7.68B
| $13.2M | 0.89% |
+180,000
|
|
||
32
Pfizer
PFE
$148B
| $12.7M | 0.86% |
500,000
-200,000
|
|
||
33
Penumbra
PEN
$14.1B
| $12.7M | 0.86% |
50,000
+10,000
|
|
||
34
Arcellx
ACLX
$3.97B
| $12.3M | 0.83% |
+150,000
|
|
||
35
Ascendis Pharma
ASND
$14B
| $11.9M | 0.81% |
+60,000
|
|
||
36
Fresenius Medical Care
FMS
$12.9B
| $11.8M | 0.8% |
450,000
-300,000
|
|
||
37
McKesson
MCK
$101B
| $11.6M | 0.78% |
15,000
+5,000
|
|
||
38
Agilent Technologies
A
$39.3B
| $11.6M | 0.78% |
90,000
+40,000
|
|
||
39
Roivant Sciences
ROIV
$16B
| $11.3M | 0.77% |
750,000
+150,000
|
|
||
40
Envista
NVST
$4.01B
| $11.2M | 0.76% |
+550,000
|
|
||
41
Intuitive Surgical
ISRG
$186B
| $11.2M | 0.76% |
+25,000
|
|
||
42
iRhythm Holdings
IRTC
$5.31B
| $11.2M | 0.76% |
65,000
+25,000
|
|
||
43
Exact Sciences
EXAS
$19.4B
| $10.9M | 0.74% |
200,000
+100,000
|
|
||
|
UPB
44
Upstream Bio Inc
UPB
$1.72B
| $10.8M | 0.73% |
+575,000
|
|
||
45
Oric Pharmaceuticals
ORIC
$1.17B
| $10.8M | 0.73% |
900,000
-350,000
|
|
||
46
Regenxbio
RGNX
$809M
| $10.6M | 0.72% |
1,100,000
+400,000
|
|
||
47
Oscar Health
OSCR
$4.52B
| $10.4M | 0.7% |
550,000
+450,000
|
|
||
48
Dyne Therapeutics
DYN
$2.98B
| $10.1M | 0.68% |
+800,000
|
|
||
49
Biohaven
BHVN
$1.83B
| $9.76M | 0.66% |
650,000
+350,000
|
|
||
50
Beam Therapeutics
BEAM
$3.48B
| $9.71M | 0.66% |
400,000
-100,000
|
|